Ajit Srinivas Divakaruni

Title: Ajit Srinivas Divakaruni: Innovator in Inflammation Modulation

Introduction

Ajit Srinivas Divakaruni is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of therapeutic methods aimed at modulating inflammation. His innovative work focuses on the modulation of intracellular coenzyme A levels, which has implications for treating various inflammatory diseases.

Latest Patents

Ajit Srinivas Divakaruni holds a patent titled "Methods and agents for modulating inflammation." This patent describes methods and agents that increase intracellular coenzyme A levels for therapeutic purposes. By increasing these levels, alternate macrophage activation is enhanced, leading to the suppression or resolution of immune responses. This approach is beneficial in treating inflammatory diseases. Conversely, decreasing intracellular coenzyme A levels can reduce alternate macrophage activation, which is advantageous in treating conditions such as NASH/NAFLD and various fibrotic diseases. Additionally, this modulation can reverse the immune-suppressing activity of tumor-associated immune cells, such as macrophages, aiding in cancer treatment. He has 1 patent to his name.

Career Highlights

Ajit Srinivas Divakaruni is affiliated with the University of California, where he continues to advance his research and innovations. His work is characterized by a commitment to understanding and addressing complex health issues through scientific inquiry and invention.

Collaborations

Some of his notable coworkers include Steven J Bensinger and Anne N Murphy. Their collaborative efforts contribute to the advancement of research in inflammation and related therapeutic strategies.

Conclusion

Ajit Srinivas Divakaruni is a key figure in the field of inflammation modulation, with a focus on innovative therapeutic methods. His contributions are paving the way for new treatments that could significantly impact the management of inflammatory diseases.